The federal contract IDV award to Veracyte, Inc. under the GSA's Medical Laboratory Testing and Analysis Services Schedule (FSS-621-II) enables multiple federal agencies, including the Department of Veterans Affairs (VA) and Defense Health Agency, to procure Veracyte's genomic testing services. The contract, valued at up to $2.3 million through July 2028, provides access to Veracyte's commercial laboratory capabilities for cancer screening and diagnosis, such as the Afirma Genomic Sequencing Classifier for thyroid nodules, Envisia Genomic Classifier for interstitial lung diseases, and Percepta Genomic Sequencing Classifier for lung cancer risk stratification. Delivery orders issued under this IDV, ranging from $38,784 to $484,800, task Veracyte with performing these specialized genomic testing services at its facilities in South San Francisco, California and Miami, Florida to support the VA's cancer detection efforts for veterans. The contract does not have any set-aside designations, allowing Veracyte, a for-profit organization, to provide these genomic testing services to federal agencies on a firm fixed price basis. Veracyte also holds a separate $600,000 Indefinite Delivery Indefinite Quantity (IDIQ) contract with the VA's Veterans Integrated Service Network 23 to provide a broader range of reference laboratory services. This enables VISN 23 hospitals and clinics to efficiently access Veracyte's commercial laboratory capabilities to supplement their internal diagnostic testing capacity for veterans in northern and central California. The testing services delivered under both the GSA Schedule and VISN 23 IDIQ contracts are intended to aid in clinical diagnosis and treatment planning for federal government patients.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| P00011 | Supplemental Agreement for work within scope | $0 | 4/2/25 | |
| P00010 | Supplemental Agreement for work within scope | $0 | 1/6/25 | |
| P00009 | Other Administrative Action | $0 | 12/27/23 | |
| P00007 | Exercise an Option | $0 | 6/20/23 | |
| P00008 | Add Subcontract Plan | $0 | 6/12/23 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36F79718D0524-36C24822N0742 | Veracyte, Inc. | $38.8k | 8/4/22 | 2/4/23 | 4/15/23 | |
Delivery Order 36F79718D0524-36C24824F0315 | Veracyte, Inc. | $484.8k | 9/1/24 | 8/31/25 | 9/1/24 | |
Delivery Order 36F79718D0524-36C26323F0055 | Veracyte, Inc. | $0 | 4/6/23 | 4/20/23 | 3/26/24 | |
Delivery Order 36F79718D0524-36C24825N0404 | Veracyte, Inc. | $97.0k | 2/5/25 | 2/4/26 | 2/4/25 | |
Delivery Order 36F79718D0524-36C24823N0381 | Veracyte, Inc. | $132.5k | 2/5/23 | 2/4/24 | 1/30/24 |
Name | Description | Size | Type (Click to sort descending) | Posted (Click to sort descending) |
|---|---|---|---|---|
FSS-621-II - Veracyte, Inc. - 36F79718D0524 | 248KB | Not listed |
Name | Description | Solicitation Number | Federal Agency | Type | Posted Date (Click to sort descending) |
|---|---|---|---|---|---|
American Institute of Toxicology, Inc. dba AIT Laboratories (621II) 621 II Medical Laboratory Testing & Analysis Services | 621II | Department of Veterans Affairs National Acquisition Center | Award Notice 1/1 | 4/9/19, 10:35 AM |